Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?
Avadel Pharmaceuticals Ownership Summary
Avadel Pharmaceuticals is owned by 7.66% institutional investors, 4.77% insiders, and 87.56% retail investors. Knoll capital management is the largest institutional shareholder, holding 0.65% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 4.16% of its assets in Avadel Pharmaceuticals shares.
AVDL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Avadel Pharmaceuticals | 7.66% | 4.77% | 87.56% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 33.68% | 9.20% | 57.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Knoll capital management | 600.00K | 0.65% | $8.44M |
Knott david m jr | 333.00K | 0.36% | $4.68M |
Schulhoff | 137.00K | 0.15% | $1.93M |
1620 investment advisors | 1.00K | 0.00% | $14.06K |
Renaissance | - | - | - |
Rtw investments, lp | - | - | - |
Advisorshares investments | - | - | - |
Point72 asset management | - | - | - |
Gendell jeffrey l | - | - | - |
Bfsg | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Knoll capital management | 600.00K | 5.68% | $8.44M |
Knott david m jr | 333.00K | 1.87% | $4.68M |
Schulhoff | 137.00K | 0.87% | $1.93M |
1620 investment advisors | 1.00K | 0.01% | $14.06K |
Renaissance | - | - | - |
Rtw investments, lp | - | - | - |
Advisorshares investments | - | - | - |
Point72 asset management | - | - | - |
Gendell jeffrey l | - | - | - |
Bfsg | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
1620 investment advisors | 1.00K | 0.01% | 1.00K |
Huntington national bank | 1.00 | - | - |
Schulhoff | 137.00K | 0.87% | - |
Knott david m jr | 333.00K | 1.87% | - |
Knoll capital management | 600.00K | 5.68% | - |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | - | - | -12.92M |
Rtw investments, lp | - | - | -8.80M |
Polar capital | - | - | -6.75M |
Gendell jeffrey l | - | - | -5.71M |
Vivo capital | - | - | -3.97M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
1620 investment advisors | 1.00K | 0.01% | 1.00K | $14.06K |
Sold Out
Holder | Change |
---|---|
Zurcher kantonalbank (zurich cantonalbank) | -19.00 |
Signaturefd | -22.00 |
Cwm | -99.00 |
First manhattan co. llc. | -100.00 |
Org partners | -129.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 10 | -92.42% | 7,025,014 | -89.75% | 7 | 0.10% | 3 | -96.05% | 1 | -96.67% |
Mar 31, 2024 | 132 | 8.20% | 68,522,967 | 22.31% | 85 | 2.18% | 76 | 40.74% | 30 | 11.11% |
Dec 31, 2023 | 122 | 11.93% | 56,021,760 | 3.17% | 62 | 1.27% | 54 | 12.50% | 27 | 3.85% |
Sep 30, 2023 | 109 | -1.80% | 54,298,994 | 3.04% | 70 | 1.03% | 48 | -17.24% | 26 | 8.33% |
Jun 30, 2023 | 111 | 11.00% | 52,698,646 | 8.91% | 82 | 1.44% | 58 | 11.54% | 24 | 9.09% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Polar Capital Healthcare Opports Inc | 4.00M | 4.16% | - |
Vanguard Total Stock Mkt Idx Inv | 2.99M | 3.10% | 4.70K |
Janus Henderson Global Life Sciences D | 2.71M | 2.82% | -37.96K |
Janus Henderson Global Life Sciences | 2.67M | 2.78% | -233.27K |
iShares Russell 2000 ETF | 2.40M | 2.50% | -5.40K |
Janus Henderson Glb Life Scn I2 USD | 1.99M | 2.08% | 9.17K |
Janus Global Life Science AUSD | 1.99M | 2.08% | -120.85K |
Polar Capital Biotech S Inc | 1.50M | 1.56% | - |
Janus Henderson Venture D | 1.17M | 1.21% | - |
Janus Henderson US Small Cap Growth | 1.17M | 1.21% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 16, 2024 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $29.00K |
Dec 28, 2023 | McCamish Mark Anthony | - | Sell | $1.09M |
Aug 11, 2023 | McCamish Mark Anthony | - | Sell | $432.61K |
Aug 14, 2023 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $28.90K |
Aug 10, 2023 | Glass Geoffrey Michael | - | Buy | $187.60K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | 1 | - |
2023 Q4 | - | 1 |
2023 Q3 | 3 | 1 |
AVDL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools